Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4676
Banco Santander
SAN
$206B
| $971K | ﹤0.01% |
268,141
-1,414,702
| -84% | -$5.22M |
|
4677
Lyell Immunopharma
LYEL
$315M
| $970K | ﹤0.01% |
3,276
-3,282
| -50% | -$983K |
|
|
STR
4678
DELISTED
Sitio Royalties
STR
| $970K | ﹤0.01% |
51,611
+6,678
| +15% | +$125K |
|
4679
Ternium
TX
$9.76B
| $970K | ﹤0.01% |
22,936
-585,814
| -96% | -$28.6M |
|
|
CASI
4680
DELISTED
CASI Pharmaceuticals
CASI
| $969K | ﹤0.01% |
81,411
-29,810
| -27% | -$403K |
|
4681
Tompkins Financial
TMP
$1.45B
| $969K | ﹤0.01% |
11,972
+4,801
| +67% | +$372K |
|
|
HLLY.WS
4682
CALL
DELISTED
Holley Inc Warrants
HLLY.WS
| $967K | ﹤0.01% |
+333,333
| New | +$890K |
|
|
VGR
4683
DELISTED
Vector Group Ltd.
VGR
| $967K | ﹤0.01% |
+106,991
| New | +$1.04M |
|
4684
PRA Group
PRAA
$666M
| $964K | ﹤0.01% |
22,877
+6,002
| +36% | +$239K |
|
4685
iShares MSCI Philippines ETF
EPHE
$146M
| $962K | ﹤0.01% |
32,346
+6,419
| +25% | +$190K |
|
|
AWH
4686
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $961K | ﹤0.01% |
19,720
-4,387
| -18% | -$271K |
|
4687
Karooooo
KARO
$1.99B
| $960K | ﹤0.01% |
32,517
-2,071
| -6% | -$70.7K |
|
4688
Orchestra BioMed
OBIO
$247M
| $960K | ﹤0.01% |
97,030
+34,004
| +54% | +$336K |
|
|
NAGE
4689
Niagen Bioscience
NAGE
$281M
| $960K | ﹤0.01% |
153,068
+50,850
| +50% | +$419K |
|
|
MMV
4690
DELISTED
MultiMetaVerse Holdings Limited Class A Ordinary Share
MMV
| $960K | ﹤0.01% |
96,171
+78,648
| +449% | +$779K |
|
4691
RE/MAX Holdings
RMAX
$195M
| $959K | ﹤0.01% |
30,792
-24,056
| -44% | -$799K |
|
|
CRHC
4692
CALL
DELISTED
Cohn Robbins Holdings Corp.
CRHC
| $959K | ﹤0.01% |
1,059,203
-88,231
| -8% | -$866K |
|
4693
Universal Corp
UVV
$1.3B
| $958K | ﹤0.01% |
19,831
+7,897
| +66% | +$401K |
|
4694
PUT
TJX Companies
TJX
$174B
| $957K | ﹤0.01% |
+14,500
| New | +$1.01M |
|
|
ACTDU
4695
DELISTED
ArcLight Clean Transition Corp. II Unit
ACTDU
| $957K | ﹤0.01% |
96,459
-315,220
| -77% | -$3.14M |
|
4696
Peoples Bancorp
PEBO
$1.5B
| $956K | ﹤0.01% |
30,235
-14,555
| -32% | -$440K |
|
4697
Carlyle Secured Lending
CGBD
$713M
| $953K | ﹤0.01% |
71,067
+33,864
| +91% | +$462K |
|
4698
CALL
Deutsche Bank
DB
$69.8B
| $953K | ﹤0.01% |
+75,000
| New | +$940K |
|
|
BITE
4699
DELISTED
Bite Acquisition Corp.
BITE
| $953K | ﹤0.01% |
97,988
+60,759
| +163% | +$588K |
|
|
APR
4700
DELISTED
Apria, Inc. Common Stock
APR
| $952K | ﹤0.01% |
25,625
-237,075
| -90% | -$7.8M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.